The Team behind Pramana  

 Driving the Science to develop Therapeutics that have the potential to be first in class treatments for multiple  diseases  

Diane Alexander

Co-Founder and CEO

Over 20 years of Capital Markets experience
Chairmans status Canaccord Genuity. Diane has taken a lead role in over $200 million of corporate finance and VC transactions.


Bryan Henry


18 years of Capital Markets experience

Chairmans status PI Financial. Bryan has taken a lead role in raising in excess of $200 million in capital through corporate finance and VC transactions


Richard Friesen, PH.D.

Scientific advisor and

Scientific advisory board member

20+ years with Merck-overseeing the discovery and early development of small molceule pharmaceuticals, many of which progressed to the clinic.  Rick's expertise spans across multiple therapeutic areas including Diabetes 

Tom Elliott MBBS, FRCPC

Director, scientific advisor and

scientific advisory board member

Clinical associate Professor at University of British Columbia
Director of clinical trials at Trials Center of Excellence-North America

David G. Parkes, PH.D.

Scientific advisor

and scientific advisory board member

Extensive Big Pharma Drug Development experience in Diabetes, Obesity and Nash, David played a pivotal role in the Discovery and development of FDA approved Blockbuster Diabetes drug, Byetta

Aaron (Arnie) H. Sadovnick

CPA – Controller  

Extensive auditing/accounting and tax practice with 18 years of capital markets experience 


Dr. David Kwok, B.SC. (Pharm), M.SC., PH.D.

Scientific advisory board member

Founded Biopharmaceutical Research Inc in 1991 and serves as its president. Dr. Kwok served in a variety of senior scientific and management posts at Health Canada from 1991 to 1998.